Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 03:58 pm IST
Share
Jiangxi Synergy Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 179.77 million compared to CNY 137.35 million a year ago. Revenue was CNY 179.77 million compared to CNY 137.35 million a year ago. Net income was CNY 26.83 million compared to CNY 20.14 million a year ago. Basic earnings per share from continuing operations was CNY 0.0869 compared to CNY 0.0653 a year ago. Diluted earnings per share from continuing operations was CNY 0.0793 compared to CNY 0.0653 a year ago.
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. 
